AAAAAA

   
Results: 1-9 |
Results: 9
Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood
Authors: Jones, D Dang, NH Duvic, M Washington, LT Huh, YO
Citation: D. Jones et al., Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood, AM J CLIN P, 115(6), 2001, pp. 885-892
In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody1F7 on human CD30+anaplastic large cell T-cell lymphoma Karpas 299
Authors: Ho, L Aytac, U Stephens, LC Ohnuma, K Mills, GB McKee, KS Neumann, C LaPushin, R Cabanillas, F Abbruzzese, JL Morimoto, C Dang, NH
Citation: L. Ho et al., In vitro and in vivo antitumor effect of the anti-CD26 monoclonal antibody1F7 on human CD30+anaplastic large cell T-cell lymphoma Karpas 299, CLIN CANC R, 7(7), 2001, pp. 2031-2040
Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial
Authors: Herbst, RS Lynch, C Vasconcelles, M Teicher, BA Strauss, G Elias, A Anderson, I Zacarola, P Dang, NH Leong, T Salgia, R Skarin, AT
Citation: Rs. Herbst et al., Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial, CANC CHEMOT, 48(2), 2001, pp. 151-159
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO
Authors: Ishii, T Ohnuma, K Murakami, A Takasawa, N Kobayashi, S Dang, NH Schlossman, SF Morimoto, C
Citation: T. Ishii et al., CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO, P NAS US, 98(21), 2001, pp. 12138-12143
Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs
Authors: Ohnuma, K Munakata, Y Ishii, T Iwata, S Kobayashi, S Hosono, O Kawasaki, H Dang, NH Morimoto, C
Citation: K. Ohnuma et al., Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs, J IMMUNOL, 167(12), 2001, pp. 6745-6755
Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint
Authors: Aytac, U Claret, FX Ho, L Sato, K Ohnuma, K Mills, GB Cabanillas, F Morimoto, C Dang, NH
Citation: U. Aytac et al., Expression of CD26 and its associated dipeptidyl peptidase IV enzyme activity enhances sensitivity to doxorubicin-induced cell cycle arrest at the G(2)/M checkpoint, CANCER RES, 61(19), 2001, pp. 7204-7210
Overexpression of wild-type and nuclear-targeted catalase modulates resistance to oxidative stress but does not alter spontaneous mutant frequencies at APRT
Authors: Schriner, SE Smith, AC Dang, NH Fukuchi, KI Martin, GM
Citation: Se. Schriner et al., Overexpression of wild-type and nuclear-targeted catalase modulates resistance to oxidative stress but does not alter spontaneous mutant frequencies at APRT, MUT RES-F M, 449(1-2), 2000, pp. 21-31
Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma
Authors: McLaughlin, P Hagemeister, FB Rodriguez, MA Sarris, AH Pate, O Younes, A Lee, MS Dang, NH Romaguera, JE Preti, AH McAda, N Cabanillas, F
Citation: P. Mclaughlin et al., Safety of fludarabine, mitoxantrone, and dexamethasone combined with rituximab in the treatment of stage IV indolent lymphoma, SEMIN ONCOL, 27(6), 2000, pp. 37-41
Chemotherapy of advanced non-small-cell lung cancer
Authors: Dang, NH Herbst, RS Skarin, AT
Citation: Nh. Dang et al., Chemotherapy of advanced non-small-cell lung cancer, LUNG BIOL H, 140, 2000, pp. 235-279
Risultati: 1-9 |